Get started
Work

796P Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111

Year: 2021
Type: article
DOI: 10.1016/j.annonc.2021.08.1238
Authors: V. Makker, M.H. Taylor, C. Aghajanian, A.L. Cohn, M.S. Brose, C. DiSimone, A. Cao, L. Suttner, A. Loboda, R. Cristescu, P. Jelinic, A. Snyder, M. Nebozhyn, J. Lunceford, R. Orlowski, L. Dutta, J. Matsui, C. Dutcus, Y. Minoshima, M. Messing
Institutions: Memorial Sloan Kettering Cancer Center, Oregon Health & Science University, Rocky Mountain Cancer Centers, Abramson Cancer Center, University of Pennsylvania, Arizona Oncology, Merck & Co., Inc., Rahway, NJ, USA (United States), Eisai (United States), Eisai (Japan), Texas Oncology
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W3204058454
FWCI: 0.196
Cites:
Cited by: 1
Related to: 10